1Ronnett B M,Zahn C M,Kurman R J,et al.Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis.A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features,site of origin,prognosis,and relationship to pseudomyxoma peritonei[J].J Am Surg Pathol,1995,19(12):1390-408.
2Alexander-Sefre F,Chandrakumaran K,Banerjee S,et al.Elevated tumour markers prior to complete tumour removal in patients with pseudomyxoma peritonei predict early recurrence[J].J Colorectal Dis,2005,7(4):382-6.
3Miner T J,Shia J,Jaques D P,et al.Long-term survival following treatment of pseudomyxoma peritonei:an analysis of surgical therapy[J].J Am Surg,2005,242(5):748-50.
同被引文献4
1Ronnett B M,Kajdacsy Balla A,Gilks C B. Mucinous borderline ovarian tumors:points of general agreement and persistent controversies regarding nomenclature,diagnostic criteria,and behavior[J].Human Pathology,2004,(08):949.
2Ronnett B M,Yan H,Kurman R J. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis[J].Cancer,2001,(01):85.
3Jess P,Iversen L H,Nielsen M B. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei:a prospective study[J].Diseases of the Colon & Rectum,2008,(06):868.
